Asset Management One Co. Ltd. grew its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,405 shares of the biopharmaceutical company’s stock after acquiring an additional 1,027 […]